14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 AXSM stock ended at $74.80. This is 0.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.64% from a day low at $74.36 to a day high of $76.32.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Jan 19, 2022 $30.30 $31.49 $28.38 $28.52 537 900
Jan 18, 2022 $28.30 $30.73 $28.27 $30.18 1 440 800
Jan 14, 2022 $28.30 $29.32 $27.77 $28.60 874 900
Jan 13, 2022 $31.45 $31.83 $29.67 $29.89 530 900
Jan 12, 2022 $33.12 $33.52 $31.21 $31.41 437 900
Jan 11, 2022 $33.63 $34.50 $32.91 $33.08 445 000
Jan 10, 2022 $32.70 $33.85 $31.86 $33.41 442 700
Jan 07, 2022 $34.05 $34.17 $32.60 $32.91 336 900
Jan 06, 2022 $33.63 $34.04 $31.73 $33.09 533 900
Jan 05, 2022 $35.59 $36.50 $32.88 $33.18 513 400
Jan 04, 2022 $37.28 $37.83 $35.07 $35.91 494 077
Jan 03, 2022 $37.93 $38.42 $36.40 $37.83 430 098
Dec 31, 2021 $37.76 $39.48 $37.38 $37.78 398 577
Dec 30, 2021 $35.37 $38.78 $35.35 $38.02 634 943
Dec 29, 2021 $36.91 $37.04 $35.21 $35.55 373 664
Dec 28, 2021 $37.13 $38.05 $36.61 $37.02 289 693
Dec 27, 2021 $38.41 $38.55 $36.90 $37.13 307 322
Dec 23, 2021 $37.82 $39.21 $37.00 $38.45 451 198
Dec 22, 2021 $38.43 $38.67 $36.28 $37.70 409 455
Dec 21, 2021 $36.14 $38.03 $35.48 $37.81 556 998
Dec 20, 2021 $34.76 $36.88 $34.25 $35.97 436 267
Dec 17, 2021 $33.15 $35.77 $32.60 $35.30 750 040
Dec 16, 2021 $33.18 $33.81 $32.51 $33.51 389 980
Dec 15, 2021 $30.81 $32.83 $29.60 $32.77 497 469
Dec 14, 2021 $31.75 $32.41 $30.22 $30.70 612 146
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT